AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) Data, Technology Stack, and Enterprise Applications
HCM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Abacus Research Legacy Abacus Umantis Applicant Management Applicant Tracking System HCM n/a 2019 2019
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
JustRelate Legacy JustRelate Fiona CMS Enterprise Content Management Content Management n/a 2013 2013
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Lucky Orange Legacy Lucky Orange Marketing Analytics CRM n/a 2022 2022
IT Decision Makers and Key Stakeholders at Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc)
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) Technographics

Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) is a Professional Services organization based in Germany, with around 1100 employees and annual revenues of $400.0 million.

Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) operates a diverse technology stack with applications such as Abacus Umantis Applicant Management, JustRelate Fiona CMS and Lucky Orange, covering areas like Applicant Tracking System, Enterprise Content Management and Marketing Analytics.

Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Abacus Research, JustRelate and Lucky Orange.

Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) recently adopted applications including Lucky Orange in 2022, Abacus Umantis Applicant Management in 2019 and JustRelate Fiona CMS in 2013, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc)’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc)’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Max-Delbrueck-Center Fuer Molekulare Medizin (Mdc) technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.